ATEC Spine is a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, self-described as focusing on surgical techniques and technology.

ATEC Spine

Molecular Devices is a life science technology innovator dedicated to enabling life science labs of the future, where innovative technology and novel research converge. The company provides integrated hardware and software solutions that enable automated workflows for various research applications, including cell line development, 3D biology, and drug screening.

Molecular Devices

Esaote focuses on medical diagnostic imaging, specifically in ultrasound, MRI, and healthcare IT, self-described as contributing to better quality healthcare.

Esaote

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Metric
Company Name	ATEC Spine	Molecular Devices	Esaote	Bioventus Inc.
Symbol				BVS
MSH ID	COM:ALPHATECSPINE	COM:MOLECULARDEVICES	COM:ESAOTE	COM:BIOVENTUS
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare
Industry	Medical Devices	Biotechnology Research	Medical Devices	Medical - Devices
Country	US		IT	US
Stage	Post-IPO Equity
Employee Count		1.00K	1.00K	995
Website	alphatecspine.com	moleculardevices.com	esaote.com	bioventus.com
LinkedIn
Founders

Metric
Market Cap			375.94M
Enterprise Value
Monthly Web Traffic	11.77K	35.69K
Web Traffic Growth	-0.08	-0.52
Valuation
Raised Capital	150M

Metric
Revenue				512.35M
Revenue (LTM)
Revenue (NTM)
Gross Profit				319.35M
EBITDA				73.38M
Operating Income				16.01M
Net Income				-156.23M
EPS				-2.49
Diluted EPS				-2.49
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.66
Operating Profit Margin				0.16
EBITDA Margin				0.14
Net Profit Margin				-0.04
Return on Equity				-0.12
Return on Assets				-0.03
Return on Capital Employed				0.13

COM:ALPHATECSPINE

ATEC Spine

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-1.82
P/B Ratio				1.60
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				1.57
EV Multiple				6.83

Metric
Days Sales Outstanding				81.96
Days Payables Outstanding				34.49
Days Inventory Outstanding				194.34
Operating Cycle				282.00
Cash Conversion Cycle				243.73
Asset Turnover				0.68

Metric
Operating Cash Flow				15.34M
Free Cash Flow				7.98M
Cash Flow to Debt				0.04
Operating Cash Flow/Sales				0.03
Free Cash Flow Yield				-0.00

Metric
Cash & Equivalents				36.96M
Accounts Receivable				10.05M
Inventory				91.33M
Goodwill				7.46M
Debt to Capitalization				0.72
Debt to Assets				0.49
Current Ratio				1.55
Quick Ratio				0.97

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.01
R&D to Revenue				0.03
SG&A to Revenue